---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-222429"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:48:59.469294+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Reneo faces two shareholder lawsuits over OnKure merger proxy; provides supplemental disclosures

## Summary
- Two complaints filed in NY Supreme Court allege misrepresentations/omissions in proxy regarding financial projections and advisor conflicts.
- Reneo denies allegations but voluntarily supplements proxy with details on Leerink's $40k prior compensation and 5% aggregate placement agent fee.
- Supplemental disclosures include unadjusted OnKure forecasts showing projected net sales up to $3B by 2042 and DCF equity value range of $180M-$290M.
- Reneo confirms no internal liquidation analysis was prepared; board relied on OnKure forecasts and $15M enterprise value ascribed to Reneo.
- Merger and concurrent PIPE expected to close; company intends to vigorously defend against litigation.

## SEC filing metadata
- accession: 0001193125-24-222429
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312524222429/0001193125-24-222429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312524222429/d844965d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-222429
- JSON: https://secwatch.observer/filing/0001193125-24-222429.json
- Plain text: https://secwatch.observer/filing/0001193125-24-222429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.